Skip to main content
. 2017 Oct 17;41(5):337–348. doi: 10.4093/dmj.2017.41.5.337

Table 1. Evidence-grading system of the Korean Diabetes Association.

Level of evidence Description
A Evidence from well-conducted, generalizable randomized controlled trials that are adequately powered, including
 - Evidence from well-conducted multicenter trials
 - Evidence from meta-analyses that incorporated quality ratings in the analysis
B Evidence from well-conducted cohort studies
 - Evidence from well-conducted prospective cohort studies or registries
 - Evidence from well-conducted meta-analyses of cohort studies
 - Evidence from well-conducted case-control studies
C Evidence from poorly controlled or uncontrolled studies
 - Evidence from randomized controlled studies with some flaws in design, method, or analysis
 - Evidence from case reports
 - Evidence from observational studies with potential bias
E Expert consensus